Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment
The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Numerous studies have provided convincing evidence that identification of germline mutations associated with hereditary cancer syndromes can lead to reductions in morbidity and...
Main Authors: | Valentina S. Vysotskaia, Gregory J. Hogan, Genevieve M. Gould, Xin Wang, Alex D. Robertson, Kevin R. Haas, Mark R. Theilmann, Lindsay Spurka, Peter V. Grauman, Henry H. Lai, Diana Jeon, Genevieve Haliburton, Matt Leggett, Clement S. Chu, Kevin Iori, Jared R. Maguire, Kaylene Ready, Eric A. Evans, Hyunseok P. Kang, Imran S. Haque |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2017-02-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/3046.pdf |
Similar Items
-
Application of Multigene Panels Testing for Hereditary Cancer Syndromes
by: Airat Bilyalov, et al.
Published: (2022-10-01) -
Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing
by: Hyunseok P. Kang, et al.
Published: (2016-06-01) -
Screening for Mutations in Hereditary Cancer Susceptibility Genes in a Region with High Endogamy in Brazil
by: Polyanna Oliveira, et al.
Published: (2023-12-01) -
What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer?
by: Ana Carolina Rathsam Leite, et al.
Published: (2022-09-01) -
Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis
by: Airat Bilyalov, et al.
Published: (2023-12-01)